Is GENPF or SBUX a better dividend investment in 2026?

GENPF currently yields 14184.40% with a 5% 5-year dividend growth rate. SBUX yields 2.75% with 5% growth. The better choice depends on your goal: GENPF offers higher current income.

What is the dividend yield difference between GENPF and SBUX?

GENPF has a forward dividend yield of 14184.40% ($2.00/share annually). SBUX yields 2.75% ($2.46/share annually). The yield gap is 14181.65 percentage points.

Home › Compare › GENPF vs SBUX

GENPF vs SBUX: Dividend Comparison 2026

GENPF yields 14184.40% · SBUX yields 2.75%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GENPF wins by $1741245461664930048.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GENPF

● Live price

14184.40%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1741245461664930048.00M

Annual income

$1,717,427,461,345,424,000,000,000.00

Full GENPF calculator →

SBUX

● Live price

2.75%

Share price

$89.59

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$157.5K

Annual income

$65,840.13

Full SBUX calculator →

Portfolio growth — GENPF vs SBUX

📍 GENPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GENPF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GENPF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GENPF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GENPF

Annual income on $10K today (after 15% tax)

$1,205,673.76/yr

After 10yr DRIP, annual income (after tax)

$1,459,813,342,143,610,500,000,000.00/yr

SBUX

Annual income on $10K today (after 15% tax)

$233.40/yr

After 10yr DRIP, annual income (after tax)

$55,964.11/yr

At 15% tax rate, GENPF beats the other by $1,459,813,342,143,610,500,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GENPF + SBUX for your $10,000?

GENPF: 50%SBUX: 50%

100% SBUX50/50100% GENPF

Portfolio after 10yr

$870622730832465024.00M

Annual income

$858,713,730,672,712,000,000,000.00/yr

Blended yield

98.63%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

GENPF

No analyst data

Altman Z

-559.1

Piotroski

1/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+16.1% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GENPF buys

SBUX buys

Politician	Chamber	Ticker	Type	Amount	Date
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Dan Newhouse	🏢 House	$SBUX	▼ Sell	$1,001 - $15,000	2025-12-11
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-10-07
Ro Khanna	🏢 House	$SBUX	▲ Buy	$15,001 - $50,000	2025-09-29
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-08-26

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGENPFSBUX

Forward yield	14184.40% ✓	2.75%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$1741245461664930048.00M ✓	$157.5K
Annual income after 10y	$1,717,427,461,345,424,000,000,000.00 ✓	$65,840.13
Total dividends collected	$1739668430966621440.00M ✓	$127.5K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: GENPF vs SBUX ($10,000, DRIP)

Year	GENPF Portfolio	GENPF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$1,429,140	$1,418,439.72	$11,107	$407.21	+$1.42M → GENPF
2	$190,982,313	$189,453,134.00	$12,512	$626.87	+$190.97M → GENPF
3	$23,865,535,334	$23,661,184,258.31	$14,366	$978.69	+$23865.52M → GENPF
4	$2,788,853,260,935	$2,763,317,138,127.58	$16,929	$1,557.50	+$2788853.24M → GENPF
5	$304,771,704,176,462	$301,787,631,187,262.06	$20,658	$2,543.80	+$304771704.16M → GENPF
6	$31,148,518,911,483,350	$30,822,413,188,014,540.00	$26,406	$4,302.22	+$31148518911.46M → GENPF
7	$2,977,381,874,110,252,500	$2,944,052,958,874,965,500.00	$35,877	$7,622.00	+$2977381874110.22M → GENPF
8	$266,187,755,143,456,800,000	$263,001,956,538,158,780,000.00	$52,741	$14,352.64	+$266187755143456.72M → GENPF
9	$22,259,813,382,715,685,000,000	$21,974,992,484,712,187,000,000.00	$85,676	$29,243.03	+$22259813382715684.00M → GENPF
10	$1,741,245,461,664,930,200,000,000	$1,717,427,461,345,424,000,000,000.00	$157,513	$65,840.13	+$1741245461664930048.00M → GENPF

GENPF vs SBUX: Complete Analysis 2026

GENPF — Stock

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.

Full GENPF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this GENPF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GENPF vs SCHD GENPF vs JEPI GENPF vs O GENPF vs KO GENPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.